Current histologic preparation methods for Mohs micrographic surgery

被引:28
作者
Robinson, JK
机构
[1] Loyola Univ, Dept Med Dermatol, Chicago, IL 60611 USA
[2] Loyola Univ, Dept Pathol, Chicago, IL 60611 USA
关键词
D O I
10.1046/j.1524-4725.2001.00339.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND. Recently Mohs micrographic surgery, which is widely used for the removal of nonmelanoma skin cancers, has been used to remove lentigo maligna with both rush permanent sections and frozen sections. Several investigators have incorporated the use of immunohistochemical techniques to aid in the interpretation of the specimens. OBJECTIVE. To determine the current practices of Mohs surgery laboratories, including the use of immunostains and automation of laboratory processes. METHODS. A total of 108 laboratories responded to a written questionnaire with 13 items about the types of tumors resected, routine stains performed, average number of slides processed per day, and use of automation and immunostains. RESULTS. Forty-nine percent of the laboratories are completely manual and 51% are automated. The Linistainer automated system, which is the predominant one used, decreased processing time by about 30% and provided an estimated 21-30% improved quality. Automation was associated with the number of slides processed. Immunostaining is performed by a limited number of laboratories which use the technique for basal and squamous cell carcinoma, lentigo maligna, and dermatofibrosarcoma protuberans. CONCLUSION. Automation of routine slide preparation with a Linistainer decreased staining variability by providing a consistent environment, and decreased processing time. Most laboratories do not perform immunostaining. The relatively high cost of reagents, lack of a reliable automated process, the additional time to process specimens, and the additional technician and physician time makes the procedure impractical for many laboratories.
引用
收藏
页码:555 / 560
页数:6
相关论文
共 29 条
[1]   A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas [J].
Bergman, R ;
Azzam, H ;
Sprecher, E ;
Manov, L ;
Munichor, M ;
Friedman-Birnbaum, R ;
Ben-Itzhak, O .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (03) :496-500
[2]   THE PROGNOSIS AND TREATMENT OF TRUE LOCAL CUTANEOUS RECURRENT MALIGNANT-MELANOMA [J].
BROWN, CD ;
ZITELLI, JA .
DERMATOLOGIC SURGERY, 1995, 21 (04) :285-290
[3]   LENTIGO-MALIGNA - THE USE OF RUSH PERMANENT SECTIONS IN THERAPY [J].
DHAWAN, SS ;
WOLF, DJ ;
RABINOVITZ, HS ;
POULOS, E .
ARCHIVES OF DERMATOLOGY, 1990, 126 (07) :928-930
[4]   MOHS SURGERY AND MALIGNANT-MELANOMA [J].
DZUBOW, LM .
DERMATOLOGIC SURGERY, 1995, 21 (04) :283-283
[5]   Mohs micrographic surgery using HMB-45 for a recurrent acral melanoma [J].
Griego, RD ;
Zitelli, JA .
DERMATOLOGIC SURGERY, 1998, 24 (09) :1003-1006
[6]   Mohs micrographic excision of lentigo maligna using Mel-5 for margin control [J].
Gross, EA ;
Andersen, WK ;
Rogers, GS .
ARCHIVES OF DERMATOLOGY, 1999, 135 (01) :15-17
[7]  
HANKE CW, 1989, J DERMATOL SURG ONC, V15, P1
[8]   RAPID STAINING WITH CARCINOEMBRYONIC ANTIGEN AIDS LIMITED EXCISION OF EXTRAMAMMARY PAGETS-DISEASE TREATED BY MOHS SURGERY [J].
HARRIS, DWS ;
KIST, DA ;
BLOOM, K ;
ZACHARY, CB .
JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1994, 20 (04) :260-264
[9]   Melan A MART-1 immunoreactivity in formalin-fixed paraffin-embedded primary and metastatic melanoma: frequency and distribution [J].
Hofbauer, GFL ;
Kamarashev, J ;
Geertsen, R ;
Boni, R ;
Dummer, R .
MELANOMA RESEARCH, 1998, 8 (04) :337-343
[10]   A pilot study comparing Toluidine blue and Hematoxylin and Eosin staining of basal cell and squamous cell carcinoma during Mohs surgery [J].
Humphreys, TR ;
Nemeth, A ;
McCrevey, S ;
Baer, SC ;
Goldberg, LH .
DERMATOLOGIC SURGERY, 1996, 22 (08) :693-697